Ophthalmic contact lens with a compressible affinity matrix

The invention relates to a contact lens for use in the treatment of ocular inflammatory pathologies. The contact lens comprises a soft porous material coupled, in certain embodiments, with detoxifying agents. Said material and/or agents contact and neutralize inflammatory mediators present in the tear fluid of ocular pathologies patients. The nature and architecture of the soft porous material allows a greater contact area between the material itself and/or detoxifying agents with inflammatory mediators, in view of the reversible compression of the soft material that allows greater lachrymal fluid turnover and fluid exchange within the contact lens upon e.g. blinking.


Year:
2016
Other identifiers:
EPO Family ID: 56137467
TTO: 6.1493
Patent number(s):
Laboratories:




 Record created 2017-05-11, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)